A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
about
The Role of Toll-Like Receptors in Hematopoietic MalignanciesImmune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaToll-like receptor agonists in cancer therapy.The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibilityGermline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.Variation in innate immunity genes and risk of multiple myelomaA genome-wide association study of marginal zone lymphoma shows association to the HLA region.Global gene expression profiling of a population exposed to a range of benzene levels.Host genetics in follicular lymphomaAssociation of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis.Risk Factors of Non-Hodgkin LymphomaToll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.Molecular signature in HCV-positive lymphomasEffects of Toll-like receptor signals in T-cell neoplasms.Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responsesDifferences in incidence and trends of haematological malignancies in Japan and the United States.The role of toll-like receptors in chronic B-cell malignancies.Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Toll-like Receptors in Chronic Lymphocytic Leukemia.The genetics of innate immunity sensors and human disease.Toll-like receptors in the pathogenesis of human B cell malignancies.Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.Toll-like receptors targeting technology for the treatment of lymphoma.Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.Reactive oxygen species enhance TLR10 expression in the human monocytic cell line THP-1.Epistatic effect of TLR-1, -6 and -10 polymorphisms on organic dust-mediated cytokine response.Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic footPolymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic meta-analysis.Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma.Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis.
P2860
Q28077740-548799CF-4250-4C5A-85DD-4ED4E815ED5AQ33887336-AA070E55-5279-472B-942C-2DB70DFF8570Q33918509-0BA5F3E0-503F-4078-A494-25D9DD457268Q34151951-DE32BC77-1270-4FDF-B851-E3F6DD440C53Q34292891-59DD9DDE-763B-4CDD-B934-E8E959D383B9Q34306330-430CB90D-0274-4967-B381-7FBCDAAB8C3DQ34881099-2F471E60-A553-4FDD-8E0E-4525FF71CF2EQ34980955-3299B71E-E00C-4338-8479-1045EAD2A001Q35038312-56608A68-C192-4A61-AFCF-B92F9B771605Q35077769-BED9051F-E0A0-453A-A027-D28631054E80Q35499320-343E7668-7ADD-4EEB-8226-750ADE0B1629Q36001708-5D2CEA2C-5A45-49F3-A0E2-9A3E7DF0A5B5Q36199986-30B20647-4F20-4A59-BE23-BF8EAF55F87BQ36293678-B15A50C1-AF55-4F12-9F21-C1AB1F3561CFQ36561773-023138D1-6988-4863-A547-FC05AD8DCCE1Q37535048-CF09BB97-7591-419B-BFF1-F1964E8117ECQ37578343-8816E030-E7A5-4BF5-83E0-38301B095FB4Q37810124-11971151-22E0-4444-A650-2F38AFAF5D22Q37952071-BF2D0482-F970-4CD2-936D-CFE86D28FF7EQ38042942-4821717D-5E2A-49D3-B681-439C4E4BD537Q38097500-DAD63D31-A160-40F3-9D38-19636EE25E7BQ38238963-F1C2F4C0-472D-4475-B792-3BD8763E09EEQ38382435-19441812-F96B-4B2A-9868-596A1652A6F0Q38948266-6EE7593A-8FF2-4A60-9D69-F02C17EA294CQ38965699-13AE24B3-4994-45DA-B8CA-382A21BEF34EQ39378247-66FEA7B4-196E-4EBD-8A2E-DEF51CD2A5F3Q39620782-F9540EFF-898E-4B38-805F-70FB6EF33E74Q40364267-AAC3AA50-279B-411A-8616-E7989A70E838Q41807877-2E9BE8CB-7119-44DB-98F8-98FED5EF9140Q44096163-B0348B5A-9DA2-4223-91AA-AF4D8A4FA276Q44756534-7E60C6B1-699E-4F9C-99B2-AF5BEE2CEA7FQ47140213-D3ACC0A5-47E4-47E1-80F8-E3205774A92FQ53667106-F93623C1-E72B-4719-8DAB-9514615A8271Q54446553-78AA08DA-7E3A-4191-8C16-24991FE8DBDE
P2860
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@en
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@nl
type
label
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@en
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@nl
prefLabel
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@en
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
A pooled investigation of Toll ...... risk of non-Hodgkin lymphoma.
@en
P2093
Andrew E Grulich
Anne Kricker
Brian P Leaderer
Lindsay M Morton
Richard K Severson
Scott Davis
Sophia S Wang
Tong-Zhang Zheng
Wendy Cozen
P2860
P304
P356
10.1093/CARCIN/BGN262
P407
P50
P577
2008-11-24T00:00:00Z